This meeting is sponsored by:
OVERVIEW
NOTE: This will now be held as an online meeting. Details of how to attend will be sent to delegates after registration.
Advanced Therapies such as genetic medicines or genetically engineered cell-based drugs are coming of age, with the recent approvals of
CAR T-cell therapies and Luxterna, Zolgensma, Onpattro and Exondys 51 demonstrating the validity of these approaches in the treatment of
a range of medical conditions. Such therapies offer the potential to treat and even cure previously intractable diseases, for example
those associated with specific genetic abnormalities.
This meeting that will provide an overview of emerging approaches the field of genetic medicines through a range of project presentations
on cutting-edge modalities and their application in a range of therapeutic areas.
Confirmed Speakers:
Early career researcher flash talks
In addition to the confirmed speakers, there will be an opportunity for early career researchers to present
a 5-10 minute talk on topics aligned to this theme in front of
the full audience Please submit a one-page abstract (using these
guidelines) by Friday 20 November 2020 to
secretariat@smr.org.uk.
Fees:
£10 student rate
£20 member rate
£45 non-member rate
AGM:
The Society's AGM will be held as a separate online event during December.
The date for this
will be confirmed in due course and details will be circulated to all members.